Navigation Links
Isis Pharmaceuticals to Present at Jefferies' 3rd Annual Healthcare Conference
Date:6/11/2009

CARLSBAD, Calif., June 11 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the Jefferies 3rd Annual Healthcare Conference on Wednesday, June 17, 2009, at 8:00 a.m. ET in New York.

A live audio webcast of the presentation will be available on the "Investor Center" section of the Company's Web site, www.isispharm.com. A replay of the presentation will be available on the Isis Web site within 48 hours and will be archived for a limited time.

About Isis Pharmaceuticals, Inc.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. The Company has successfully commercialized the world's first antisense drug and has 19 drugs in development. Isis' drug development programs are focused on treating cardiovascular, metabolic and severe neurodegenerative diseases and cancer. Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases. Isis and Alnylam Pharmaceuticals are joint owners of Regulus Therapeutics Inc., a company focused on the discovery, development and commercialization of microRNA therapeutics. Isis also has made significant innovations beyond human therapeutics resulting in products that other companies, including Abbott, are commercializing. As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,600 issued patents worldwide. Additional information about Isis is available at www.isispharm.com.


'/>"/>
SOURCE Isis Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... SD (PRWEB) , ... July 28, 2015 , ... Peter Forbes, President of the Veterans ... of the Vietnam War Inc. and the Veterans Coalition, is spearheading a campaign to help ... , The UVBH teaches Veterans life and trade skills. Forbes and the UVBH assists and ...
(Date:7/27/2015)... ... July 28, 2015 , ... Combination Product GMP Compliance:, Understanding FDA’s New ... http:// http://www.fdanews.com/comboproductgmpcompliance , Manufacturing a drug or device is hard ... can get messy in a hurry. In a 46-page draft guidance released in January, ...
(Date:7/27/2015)... ... July 28, 2015 , ... The National Association of Professional Women (NAPW) ... Woman of the Year Circle. She is recognized with this prestigious distinction for leadership ... is the nation’s leading networking organization exclusively for professional women. , “I’m pleased to ...
(Date:7/27/2015)... CA (PRWEB) , ... July 27, 2015 , ... ... healthcare today, especially in wound center management. Earlier this year Wound Care ... care education and training for WCA wound centers. Customized learning paths allow ...
(Date:7/27/2015)... ... July 27, 2015 , ... In a piece published July ... of plastic surgery and explained why people should not shy away from their own ... excesses of the few and celebrate it for the modern wonder that it is.” ...
Breaking Medicine News(10 mins):Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 2Health News:Veterans Fund of the United States Launches “Adopt A Homeless Veteran” Campaign 3Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 2Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 3Health News:FDAnews Announces — Combination Product GMP Compliance: Understanding FDA’s New Streamline Approach Webinar, Aug. 19, 2015 4Health News:NAPW Inducts Deana Skidmore, Assistant Director of Nursing at Wilton Meadows Rehablilitation and Health Care Center, Into its VIP Woman of the Year Circle 2Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 2Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 3Health News:Recent Op-Ed Defending Plastic Surgery Highlights the Personal Side of Cosmetic Procedures, says Beverly Hills Physicians 2
... (USEPA) has awarded nearly $700,000 to Dionysios Dionysiou and ... , The USEPA awarded the grant of $698,689 ... understanding of how toxins produced by cyanobacteria (blue-green algae) ... a process used to disinfect drinking water. The research ...
... of teens who report solely positive benefits from not ... new study by scientists at the University of California, ... should give teens guidance in coping with both the ... negative experiences of refraining from them, the researchers say. ...
... Mass., Jan. 8 Haemonetics,Corporation (NYSE: HAE ) will announce its Q3FY08 ... conference call., Conference Call Dial-In Information ... 935-8754 (International) ID: 30405896 This ... the replay, please dial:, (800) 642-1687 ...
... Isolagen(TM), Inc. (Amex: ILE ),announced today that Nicholas ... of Isolagen, will present at the 26th Annual,JPMorgan Healthcare ... Time) / 11:00 a.m. (Eastern Time). The conference will ... Francisco, California., The presentation will be webcast live ...
... to be provided to select Red Cross Donor Centers and ... provided for people who give or attempt to give blood, ... Blood,Donor Month, Dunkin, Donuts will recognize American Red Cross Donors,Employees ... Beginning Thursday, January 17 through Thursday, January 31, all donors,at ...
... As 2008 begins, millions of Americans are having to dig deeper ... see a doctor. , The reason" Higher co-payments that took effect ... of health insurance by making employees and retirees pay more. ... co-pays should go down at least for some people taking ...
Cached Medicine News:Health News:EPA grant to UC engineering makes for a better environment 2Health News:EPA grant to UC engineering makes for a better environment 3Health News:EPA grant to UC engineering makes for a better environment 4Health News:EPA grant to UC engineering makes for a better environment 5Health News:Teens find the benefits of not having sex decline with age 2Health News:Teens find the benefits of not having sex decline with age 3Health News:Isolagen Inc. to Present at the 26th Annual JPMorgan Healthcare Conference 2Health News:Dunkin' Donuts Celebrates the New Year by Supplying Goodies to Michigan's American Red Cross 2Health News:Study proves the co-pay connection in chronic disease 2Health News:Study proves the co-pay connection in chronic disease 3Health News:Study proves the co-pay connection in chronic disease 4
(Date:7/27/2015)... July 27, 2015  Array BioPharma Inc. ... for the fourth quarter and full year ... call to discuss those results on Monday, ... Officer will lead the call. ... 464-3927Toll:(765) 507-2598Pass Code: 68380312 Webcast, including Replay ...
(Date:7/27/2015)... ALBANY, New York , July 27, 2015 ... Transparency Market Research "Bionics Market - Global Industry Analysis, Size, ... market was valued at USD 7.96 billion in 2014, growing ... account for USD 20.49 billion in 2021. The ... in the number of accidents, which is leading to paralysis ...
(Date:7/27/2015)... DUBLIN , July 20, 2015 Research ... of the "Medical Device Regulation in Asia/Pacific Markets ... Now that the European Medical Device market is well ... . China , together with ... are in the process of implementing, their own medical ...
Breaking Medicine Technology:Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 2Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 3Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 4Medical Device Regulation in Asia/Pacific Markets Seminar: London, UK - 21st, 22nd of September 2015 2
... GPP Plays Critical Role in Moving HIV Prevention Research Agenda Forward ... VIENNA , July 23 ... Guidelines for Biomedical HIV Prevention Trials were released yesterday at the International ... aim to provide trial funders, sponsors, and implementers with systematic guidance on how ...
... July 22 Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ... received a letter from the Nasdaq Stock Market stating that the ... $1.00 per share for 30 consecutive business days and ... bid price requirement for continued listing set forth in Marketplace Rule ...
Cached Medicine Technology:New Edition of Guidelines for Involving Communities in HIV Prevention Research Released at International AIDS Conference 2Poniard Pharmaceuticals Receives NASDAQ Deficiency Notice Related to Minimum Bid Price 2Poniard Pharmaceuticals Receives NASDAQ Deficiency Notice Related to Minimum Bid Price 3
Long handle occluders are approximately 9 inches long....
Short handle occluders are about 6 inches long....
Manual Lensmeter....
Manual Lensmeter....
Medicine Products: